Rossmore Private Capital Edwards Lifesciences Corp Transaction History

Rossmore Private Capital

$914 Million
Q3 2025

A detailed history of Rossmore Private Capital transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rossmore Private Capital holds 18,540 shares of EW stock, worth $1.6 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

18,540

Previous 18,550 0.05%

Holding current value

$1.6 Million

Previous $1.45 Million 0.62%

% of portfolio

0.16%

Previous 0.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$73.75 - $81.83 $737 - $818	-10 Reduced 0.05%	18,540 $1.44 Million
Q2 2025 Aug 07, 2025	SELL	$67.07 - $78.22 $2,079 - $2,424	-31 Reduced 0.17%	18,550 $1.45 Million
Q1 2025 May 12, 2025	SELL	$67.95 - $76.19 $17,870 - $20,037	-263 Reduced 1.4%	18,581 $1.35 Million
Q4 2024 Feb 13, 2025	SELL	$64.54 - $75.92 $645 - $759	-10 Reduced 0.05%	18,844 $1.4 Million
Q3 2024 Nov 05, 2024	SELL	$59.7 - $93.78 $29,850 - $46,890	-500 Reduced 2.58%	18,854 $1.24 Million

Q2 2024 Aug 12, 2024	SELL	$84.3 - $94.31 $20,316 - $22,728	-241 Reduced 1.23%	19,354 $1.79 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $10,155 - $13,378	-140 Reduced 0.71%	19,595 $1.87 Million
Q4 2023 Feb 07, 2024	SELL	$61.71 - $77.76 $617 - $777	-10 Reduced 0.05%	19,735 $1.5 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $4,572 - $6,163	-66 Reduced 0.33%	19,745 $1.37 Million
Q1 2023 May 02, 2023	SELL	$74.26 - $84.51 $237,632 - $270,432	-3,200 Reduced 13.91%	19,811 $1.64 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $683 - $874	-10 Reduced 0.04%	23,011 $1.72 Million
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $7,445 - $9,147	-70 Reduced 0.3%	23,021 $2.98 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $26,139 - $31,178	-254 Reduced 1.09%	23,091 $2.61 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $22,217 - $27,761	-265 Reduced 1.12%	23,345 $2.42 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $44,304 - $56,380	-618 Reduced 2.55%	23,610 $2.15 Million
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $1.63 Million - $2.12 Million	24,228 New	24,228 $1.93 Million
Q2 2020 Aug 05, 2020	SELL	$57.54 - $76.95 $327,632 - $438,153	-5,694 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$52.41 - $81.0 $298,422 - $461,214	5,694 New	5,694 $1.07 Million

Others Institutions Holding EW

# of Institutions

1,458

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.

Account

Rossmore Private Capital Edwards Lifesciences Corp Transaction History